Compare CALY & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CALY | TMDX |
|---|---|---|
| Founded | 1982 | 1998 |
| Country | United States | United States |
| Employees | 28000 | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.5B |
| IPO Year | N/A | 2019 |
| Metric | CALY | TMDX |
|---|---|---|
| Price | $18.56 | $75.73 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 9 |
| Target Price | $16.50 | ★ $148.22 |
| AVG Volume (30 Days) | ★ 1.8M | 778.5K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 382.18 |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | ★ $605,494,000.00 |
| Revenue This Year | $9.70 | $24.25 |
| Revenue Next Year | $3.01 | $18.75 |
| P/E Ratio | ★ $64.24 | $378.73 |
| Revenue Growth | N/A | ★ 37.13 |
| 52 Week Low | $12.26 | $60.11 |
| 52 Week High | $20.28 | $156.00 |
| Indicator | CALY | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 55.98 | 54.20 |
| Support Level | $17.71 | $64.87 |
| Resistance Level | $19.36 | $79.60 |
| Average True Range (ATR) | 0.62 | 3.15 |
| MACD | -0.12 | 0.46 |
| Stochastic Oscillator | 35.66 | 66.51 |
Callaway Golf Co is a golf equipment, gear and apparel company with a portfolio of world-wide brands, including Callaway Golf, Odyssey, TravisMathew, and OGIO. Callaway designs, manufactures, and sells high-performance golf clubs, golf balls, apparel, bags, and other accessories-setting the standard for performance in the game of golf. The company has two operating and reportable business segments: Golf Equipment and Apparel, Gear and Other. Geographically, the company operates in United States, Europe, Asia, and Rest of World, of which it derives maximum revenue from United States.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.